GL1X · GenesisL1 explorer

UniProt A0A140N7N4

NADH-quinone oxidoreductase subunit A (A0A140N7N4)

NADH-quinone oxidoreductase subunit A (UniProt A0A140N7N4), EC 7.1.1.-: 11 experimental structures on GenesisL1, 2 ligands bound, 35 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
A0A140N7N4
Protein
NADH-quinone oxidoreductase subunit A
EC
7.1.1.-
Experimental structures
11
Predicted models
0
Ligands
2
Pockets
35 · 11 records with a druggable one

Structures

11 records of A0A140N7N4 in the MolNFT archive: 11 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
7P61Complex I from E. coli, DDM-purified, with NADH, Resting stateelectron microscopyA—5 (best 0.74)
7P62Complex I from E. coli, DDM-purified, Apo, Resting stateelectron microscopyA—3 (best 0.72)
7P63Complex I from E. coli, DDM/LMNG-purified, under Turnover at pH 6, Closed stateelectron microscopyA3PE4 (best 0.79)
7P64Complex I from E. coli, DDM/LMNG-purified, under Turnover at pH 6, Open stateelectron microscopyA3PE4 (best 0.84)
7P69Complex I from E. coli, DDM/LMNG-purified, under Turnover at pH 6, Resting stateelectron microscopyA3PE, LFA3 (best 0.72)
7P7CComplex I from E. coli, DDM/LMNG-purified, Apo, Open stateelectron microscopyA3PE3 (best 0.75)
7P7EComplex I from E. coli, DDM/LMNG-purified, Apo, Resting stateelectron microscopyA3PE, LFA2 (best 0.71)
7P7JComplex I from E. coli, DDM/LMNG-purified, with DQ, Open stateelectron microscopyA3PE3 (best 0.76)
7P7KComplex I from E. coli, DDM/LMNG-purified, with DQ, Resting stateelectron microscopyA3PE3 (best 0.74)
7P7LComplex I from E. coli, DDM/LMNG-purified, with NADH and FMN, Open stateelectron microscopyA3PE2 (best 0.74)
7P7MComplex I from E. coli, DDM/LMNG-purified, inhibited by Piericidin A, Open stateelectron microscopyA3PE3 (best 0.76)

Ligands

  • 3PE · 1,2-diacyl-sn-glycero-3-phosphoethanolamine · in 9 records
  • LFA · Eicosane · in 2 records

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.